In September 2025, analysts highlighted that the FDA waived the advisory committee meeting for Aquestive Therapeutics’ New Drug Application for Anaphylm, a needle-free, orally delivered epinephrine ...
Aquestive Therapeutics (NASDAQ:AQST), a biopharmaceutical company specializing in orally administered therapeutics, is garnering attention from investors and analysts alike as it approaches a critical ...
Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Amphastar Pharmaceuticals, Inc. before investing. In this article, we go over a ...
If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by progressive surfactant accumulation and hypoxemia caused by autoantibodies against granulocyte–macrophage ...
Please provide your email address to receive an email when new articles are posted on . The number of children who received repeat epinephrine dropped as time passed since the first dose. About 95% of ...
New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025 Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE ...
June 25 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...
WISCONSIN RAPIDS, Wis. (WSAW) - Golden Sands Speedway in Wisconsin Rapids hosted an event to raise awareness for epinephrine. A 20-year-old man passed away from an unknown allergy with no access to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results